Form 8K Acrivon Therapeutics Inc For: 13 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Acrivon Therapeutics Inc (ACRV)
Acrivon Therapeutics Inc stock price live, this page displays NASDAQ ACRV stock exchange data. View the ACRV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Acrivon Therapeutics Inc real time stock price chart below.
What Is the Acrivon Therapeutics Inc Stock Price Today?
The Acrivon Therapeutics Inc stock price today is 1.27.
What Is the Stock Symbol for Acrivon Therapeutics Inc?
The stock symbol for Acrivon Therapeutics Inc is ""ACRV.""
What Stock Exchange Does Acrivon Therapeutics Inc Trade On?
Acrivon Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Acrivon Therapeutics Inc a Good Stock to Buy?
Determining whether Acrivon Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACRV quote. (ISIN: US0048901096)
What Is the Acrivon Therapeutics Inc Stock Price Today?
The Acrivon Therapeutics Inc stock price today is 1.27.
What Is the Stock Symbol for Acrivon Therapeutics Inc?
The stock symbol for Acrivon Therapeutics Inc is ""ACRV.""
What Stock Exchange Does Acrivon Therapeutics Inc Trade On?
Acrivon Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Acrivon Therapeutics Inc a Good Stock to Buy?
Determining whether Acrivon Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACRV quote. (ISIN: US0048901096)
NASDAQ
Currency in USD
1.27
-0.02(-1.55%)
Closed·
After Hours
1.24-0.03(-2.29%)
·
Fair Value
An estimate of a Acrivon Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.24
1.32
52 wk Range
1.05
10.16
ACRV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ACRV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Acrivon Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.241.32
52 wk Range
1.0510.16
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACRV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Acrivon Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
11.33
Upside
+792.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Acrivon Therapeutics Inc Company Profile
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts.
Acrivon Therapeutics Inc SWOT Analysis
Precision Oncology | Acrivon Therapeutics leads with ACR-368, showing promising results in endometrial cancer treatment and leveraging its innovative AP3 platform for targeted therapies |
Pipeline Potential | Explore ACR-2316's progress as a dual WEE1/PKMYT1 inhibitor and its potential to overcome limitations of existing agents in the targeted oncology space |
Market Positioning | Analyst targets range from $17 to $30 per share, reflecting confidence in Acrivon's unique approach and strong initial clinical data compared to current treatments |
Future Prospects | Delve into Acrivon's strategies for expanding indications, potential partnerships, and the impact of its precision medicine approach on the competitive oncology landscape |
Compare ACRV to Peers and Sector
Metrics to compare | ACRV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACRVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −3.3x | −0.5x | |
PEG Ratio | −0.02 | 0.01 | 0.00 | |
Price/Book | 0.2x | 2.5x | 2.6x | |
Price / LTM Sales | - | 9.2x | 3.3x | |
Upside (Analyst Target) | - | 194.7% | 43.4% | |
Fair Value Upside | Unlock | 4.9% | 7.1% | Unlock |
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 11.33
(+792.39% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.51 / -1.01
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Acrivon Therapeutics Trade On?
Acrivon Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Acrivon Therapeutics?
The stock symbol for Acrivon Therapeutics is "ACRV."
What Is the Acrivon Therapeutics Market Cap?
As of today, Acrivon Therapeutics market cap is 40.45M.
What Is Acrivon Therapeutics's Earnings Per Share (TTM)?
The Acrivon Therapeutics EPS (TTM) is -2.22.
When Is the Next Acrivon Therapeutics Earnings Date?
Acrivon Therapeutics will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is ACRV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Acrivon Therapeutics Stock Split?
Acrivon Therapeutics has split 0 times.
How Many Employees Does Acrivon Therapeutics Have?
Acrivon Therapeutics has 77 employees.
What is the current trading status of Acrivon Therapeutics (ACRV)?
As of 08 Aug 2025, Acrivon Therapeutics (ACRV) is trading at a price of 1.27, with a previous close of 1.29. The stock has fluctuated within a day range of 1.24 to 1.32, while its 52-week range spans from 1.05 to 10.16.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.